Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2020

Karen Rothkin

June 16, 2020 Related Topics: Fee Schedules, Physician Dispensing, Prescription Drugs and Opioids, Treatment Guidelines, Rx National Inventories

Across the country, states are grappling with an array of different regulatory strategies, overseen by different agencies, to address drugs prescribed to workers for their injuries.

This report provides policymakers and system stakeholders with a basic understanding of the different strategies adopted by all 50 states and the District of Columbia, and points to the regulations for those seeking more detail.

It also provides information on some of the most prominent prescription drug issues stakeholders are concerned about today, such as the following:

  • Rules for Limiting and Monitoring Opioid Prescriptions
  • Medical Marijuana Regulations
  • Workers’ Compensation Drug Formularies
  • Prescription Drug Monitoring Programs
  • Price Regulations for Pharmacy- and Physician-Dispensed Drugs
  • Drug Testing Regulations

The tables in this report were compiled from completed surveys of two agencies for each of the 50 states and the District of Columbia as of January 1, 2020.

Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2020. Karen Rothkin with the assistance of Elizabeth Hopkins. June 2020. WC-20-26.


Copyright: WCRI

pdf download

pdf, 399KB

Reports are free for members.

If you are a member, please login here


*Temporary membership will allow you to download the study represented here

Research Questions:

  • What strategies is my state using to limit and monitor opioid prescriptions?
  • How are states regulating uses of medical marijuana?
  • Which states have adopted a drug formulary for workers’ compensation?
  • Across the nation, how different are workers’ compensation maximum prices?
  • Which states allow physicians to dispense prescription drugs?

Contact WCRI

To obtain your member login or to answer any questions or concern you may have, please contact us here.